STALEY CAPITAL ADVISERS’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $968K | Hold |
8,045
| – | – | 0.04% | 110 |
|
|
2025
Q4 | $847K | Hold |
8,045
| – | – | 0.03% | 119 |
|
|
2025
Q3 | $675K | Hold |
8,045
| – | – | 0.03% | 128 |
|
|
2025
Q2 | $637K | Hold |
8,045
| – | – | 0.03% | 128 |
|
|
2025
Q1 | $722K | Hold |
8,045
| – | – | 0.03% | 122 |
|
|
2024
Q4 | $800K | Hold |
8,045
| – | – | 0.04% | 119 |
|
|
2024
Q3 | $914K | Hold |
8,045
| – | – | 0.04% | 113 |
|
|
2024
Q2 | $996K | Sell |
8,045
-122
| -1% | -$15.7K | 0.05% | 105 |
|
|
2024
Q1 | $1.08M | Hold |
8,167
| – | – | 0.05% | 103 |
|
|
2023
Q4 | $890K | Hold |
8,167
| – | – | 0.04% | 108 |
|
|
2023
Q3 | $841K | Sell |
8,167
-399
| -5% | -$43K | 0.05% | 105 |
|
|
2023
Q2 | $988K | Buy |
8,566
+15
| +0.2% | +$1.7K | 0.05% | 100 |
|
|
2023
Q1 | $910K | Hold |
8,551
| – | – | 0.05% | 104 |
|
|
2022
Q4 | $949K | Hold |
8,551
| – | – | 0.06% | 99 |
|
|
2022
Q3 | $736K | Buy |
8,551
+1,142
| +15% | +$102K | 0.05% | 104 |
|
|
2022
Q2 | $675K | Hold |
7,409
| – | – | 0.04% | 108 |
|
|
2022
Q1 | $608K | Sell |
7,409
-100
| -1% | -$7.88K | 0.03% | 116 |
|
|
2021
Q4 | $575K | Buy |
7,509
+100
| +1% | +$7.96K | 0.03% | 119 |
|
|
2021
Q3 | $556K | Hold |
7,409
| – | – | 0.03% | 117 |
|
|
2021
Q2 | $576K | Sell |
7,409
-911
| -11% | -$67.8K | 0.03% | 115 |
|
|
2021
Q1 | $612K | Sell |
8,320
-773
| -9% | -$57K | 0.03% | 118 |
|
|
2020
Q4 | $710K | Hold |
9,093
| – | – | 0.04% | 102 |
|
|
2020
Q3 | $720K | Hold |
9,093
| – | – | 0.05% | 100 |
|
|
2020
Q2 | $671K | Buy |
9,093
+1,013
| +13% | +$76.3K | 0.05% | 101 |
|
|
2020
Q1 | $593K | Hold |
8,080
| – | – | 0.05% | 97 |
|
|
2019
Q4 | $701K | Hold |
8,080
| – | – | 0.05% | 107 |
|
|
2019
Q3 | $649K | Buy |
8,080
+4,910
| +155% | +$394K | 0.05% | 102 |
|
|
2019
Q2 | $254K | Hold |
3,170
| – | – | 0.02% | 148 |
|
|
2019
Q1 | $252K | Sell |
3,170
-1,222
| -28% | -$91.4K | 0.02% | 142 |
|
|
2018
Q4 | $320K | Hold |
4,392
| – | – | 0.03% | 126 |
|
|
2018
Q3 | $297K | Hold |
4,392
| – | – | 0.02% | 135 |
|
|
2018
Q2 | $254K | Sell |
4,392
-1,692
| -28% | -$95.5K | 0.02% | 142 |
|
|
2018
Q1 | $316K | Sell |
6,084
-1,770
| -23% | -$95.6K | 0.02% | 118 |
|
|
2017
Q4 | $422K | Buy |
7,854
+2,216
| +39% | +$123K | 0.03% | 106 |
|
|
2017
Q3 | $344K | Hold |
5,638
| – | – | 0.03% | 122 |
|
|
2017
Q2 | $345K | Sell |
5,638
-157
| -3% | -$9.56K | 0.03% | 125 |
|
|
2017
Q1 | $351K | Buy |
5,795
+79
| +1% | +$4.79K | 0.03% | 103 |
|
|
2016
Q4 | $321K | Hold |
5,716
| – | – | 0.03% | 102 |
|
|
2016
Q3 | $340K | Hold |
5,716
| – | – | 0.03% | 99 |
|
|
2016
Q2 | $314K | Hold |
5,716
| – | – | 0.03% | 99 |
|
|
2016
Q1 | $289K | Sell |
5,716
-314
| -5% | -$15.4K | 0.03% | 104 |
|
|
2015
Q4 | $304K | Sell |
6,030
-577
| -9% | -$29.1K | 0.04% | 99 |
|
|
2015
Q3 | $311K | Buy |
6,607
+367
| +6% | +$19.5K | 0.04% | 100 |
|
|
2015
Q2 | $339K | Hold |
6,240
| – | – | 0.04% | 98 |
|
|
2015
Q1 | $342K | Sell |
6,240
-629
| -9% | -$35.6K | 0.04% | 93 |
|
|
2014
Q4 | $372K | Hold |
6,869
| – | – | 0.04% | 91 |
|
|
2014
Q3 | $389K | Buy |
6,869
+1,246
| +22% | +$70K | 0.05% | 90 |
|
|
2014
Q2 | $310K | Hold |
5,623
| – | – | 0.04% | 103 |
|
|
2014
Q1 | $305K | Hold |
5,623
| – | – | 0.04% | 103 |
|
|
2013
Q4 | $269K | Sell |
5,623
-45
| -0.8% | -$2.06K | 0.04% | 104 |
|
|
2013
Q3 | $257K | Buy |
5,668
+45
| +0.8% | +$2.06K | 0.04% | 99 |
|
|
2013
Q2 | $249K | Buy |
+5,623
| New | +$251K | 0.04% | 93 |
|
Other funds holding MRK
VCM
VPM
STALEY CAPITAL ADVISERS's MRK Position: Q1 2026 in Review
STALEY CAPITAL ADVISERS held its Merck (MRK) position steady in Q1 2026 at 8,045 shares worth $968K. The position accounts for 0.04% of the portfolio, ranked #110.
STALEY CAPITAL ADVISERS first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.08M in Q1 2024. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- STALEY CAPITAL ADVISERS held 8,045 shares of Merck worth $968K as of Q1 2026.
- STALEY CAPITAL ADVISERS left its Merck share count unchanged in Q1 2026.
- Merck made up 0.04% of STALEY CAPITAL ADVISERS's portfolio in Q1 2026, its #110 holding.
- STALEY CAPITAL ADVISERS first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- STALEY CAPITAL ADVISERS's Merck position peaked at $1.08M in Q1 2024.
- 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on STALEY CAPITAL ADVISERS's 13F filing for Q1 2026, filed 29 Apr 2026.